Sanofi, Apricus, WIPO, Nestle: Intellectual PropertyVictoria Slind-Flor
Sanofi-Aventis SA and Abbott Laboratories won a U.S. trial seeking to halt Glenmark Pharmaceuticals Ltd.’s sales of a generic version of their Tarka hypertension drug. Abbott was awarded $16 million in damages.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.